Vivos Therapeutics, Inc. (VVOS) Insider Trading Activity

NASDAQ$0.1132
Market Cap
$1.53M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
105 of 849
Rank in Industry
16 of 107

VVOS Insider Trading Activity

VVOS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,813,858
1
100
Sells
$0
0
0

Related Transactions

Skaff Michael C10 percent owner
1
$1.81M
0
$0
$1.81M

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related …

Insider Activity of Vivos Therapeutics, Inc.

Over the last 12 months, insiders at Vivos Therapeutics, Inc. have bought $1.81M and sold $0 worth of Vivos Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Vivos Therapeutics, Inc. have bought $620,159 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Skaff Michael C (10 percent owner) — $1.81M.

The last purchase of 1,353,625 shares for transaction amount of $1.81M was made by Skaff Michael C (10 percent owner) on 2026‑03‑31.

List of Insider Buy and Sell Transactions, Vivos Therapeutics, Inc.

2026-03-31PurchaseSkaff Michael C10 percent owner
1.35M
26.1%
$1.34
$1.81M
-64.97%
2023-06-20PurchaseHuntsman Ronald KirkChief Executive Officer
14,000
0.059%
$0.53
$7,420
-56.26%
2023-06-16PurchaseHuntsman Ronald KirkChief Executive Officer
15,000
0.065%
$0.54
$8,050
-53.76%
2023-06-15PurchaseHuntsman Ronald KirkChief Executive Officer
21
<0.0001%
$0.50
$11
-57.84%
2023-06-14PurchaseHuntsman Ronald KirkChief Executive Officer
10,000
0.0415%
$0.49
$4,900
-50.04%
2022-12-23PurchaseHuntsman Ronald KirkChief Executive Officer
20,000
0.0911%
$0.50
$10,000
-27.91%
2022-05-31PurchaseHuntsman Ronald KirkChief Executive Officer
8,000
0.0377%
$2.03
$16,240
-64.04%
2021-09-21PurchaseHuntsman Ronald KirkChief Executive Officer
5,000
0.0241%
$4.31
$21,550
-50.23%
2021-08-17PurchaseHuntsman Ronald KirkChief Executive Officer
5,000
0.0214%
$3.00
$15,000
-26.01%
2021-05-25PurchaseHuntsman Ronald KirkChief Executive Officer
4,000
0.0198%
$5.38
$21,520
-43.81%
2021-05-25PurchaseAmman Bradford K.Chief Financial Officer
1,000
0.0049%
$5.29
$5,290
-43.81%
2020-12-24PurchaseAmman Bradford K.Chief Financial Officer
1,000
0.0078%
$7.38
$7,380
-29.54%
2020-12-23PurchaseHuntsman Ronald KirkChief Executive Officer
1,000
0.0078%
$7.27
$7,267
-27.97%
2020-12-11PurchaseHuntsman Ronald KirkChief Executive Officer
500
0.0037%
$8.50
$4,250
-40.16%
Total: 14
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Skaff Michael C10 percent owner
1353625
9.7421%
$148,628.0310
Huntsman Ronald KirkChief Executive Officer
86521
0.6227%
$9,500.01110
<0.0001%
Amman Bradford K.Chief Financial Officer
2000
0.0144%
$219.6020
<0.0001%
*Gray background shows insiders who have made transactions during last year

VVOS Institutional Investors: Active Positions

Increased Positions8+33.33%328,676+45.35%
Decreased Positions7-29.17%346,287-47.77%
New Positions<1New14,776New
Sold Out Positions4Sold Out339,319Sold Out
Total Postitions25+4.17%707,220-2.43%

VVOS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Connective Capital Management, Llc$506.002.22%200,000+200,000New2025-09-30
Strategic Wealth Investment Group, Llc$253.001.11%100,000+100,000New2025-09-30
Vanguard Group Inc$231.001.02%91,461+48,827+114.53%2025-09-30
Geode Capital Management, Llc$135.000.59%53,289-4,613-7.97%2025-09-30
Cutter & Co Brokerage, Inc.$124.000.55%49,100+11,000+28.87%2025-03-31
B. Riley Wealth Advisors, Inc.$110.000.48%43,531-26,000-37.39%2025-09-30
Drw Securities, Llc$105.000.46%41,466+41,466New2025-09-30
Commonwealth Equity Services, Llc$104.000.46%41,00000%2025-09-30
Renaissance Technologies Llc$99.000.44%39,279+39,279New2025-09-30
Blackrock, Inc.$70.000.31%27,817+27,817New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.